FDA Alerts Providers to Defibrillator Recall

Feb 12, 2018 - 04:09 PM

Phillips Electronics North America Corp. has recalled 71 HeartStart MRx defibrillators produced in September and October 2016 due to a defect that may cause the device to fail, the Food and Drug Administration announced Friday. If used in automated external defibrillator mode after failing, the device will not delivery patient therapy, which may lead to serious patient injury or death, the agency said. For more information and a list of affected devices, see the FDA notice.

Related News Articles

Headline
Next listening session in AHA’s disability health series to focus on community partnerships
The second listening session in the AHA’s series on disability health will focus on community partnerships and is scheduled for Oct. 28 at 1 p.m. ET. These…
Headline
AHA podcast explores the cost of health disparities and how to respond
In this conversation, Brian Peters, CEO of the Michigan Health & Hospital Association, explores the connection between health disparities, healthcare costs…
AHA Cyber Intel
Making Headway Toward Cyber Resilience
While we may feel inundated with alarming news about escalating cyber threats against healthcare organizations, there is also some good news. Let’s explore how…
Headline
FDA issues draft guidance on premarket submissions of robotically-assisted surgical devices
The Food and Drug Administration released draft guidance Sept. 24 that includes recommendations on non-clinical testing, clinical data and labeling for…
Headline
Webinar explores how hospitals can use data-informed strategies to improve health outcomes and reduce costs
The AHA will host a webinar on Nov. 12 at 2 p.m. ET exploring the AHA’s Economic Impact of Disparities in Health Outcomes Resource Guide which helps hospital…
Headline
Cyclospora outbreak linked to iceberg lettuce declared over
A multistate cyclospora outbreak linked to iceberg lettuce has been declared over, the Centers for Disease Control and Prevention and Food and Drug…